MedPath

MAYO CLINIC

MAYO CLINIC logo
🇺🇸United States
Ownership
Subsidiary
Established
1889-01-01
Employees
10K
Market Cap
-
Website
http://www.mayoclinic.org

A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis

Not Applicable
Recruiting
Conditions
Obesity
Ulcerative Colitis
Interventions
Device: Apollo Endoscopic Suture System
Behavioral: Lifestyle Intervention
First Posted Date
2023-02-22
Last Posted Date
2024-11-15
Lead Sponsor
Mayo Clinic
Target Recruit Count
24
Registration Number
NCT05739162
Locations
🇺🇸

Mayo Clinic Minnesota, Rochester, Minnesota, United States

Efficacy of Nerve Blocks for Episodic Migraine

First Posted Date
2023-02-21
Last Posted Date
2024-03-13
Lead Sponsor
Mayo Clinic
Target Recruit Count
60
Registration Number
NCT05734625
Locations
🇺🇸

Mayo Clinic in Rochester, Rochester, Minnesota, United States

Steroids in Occipital Nerve Block for Treatment of Headache

Phase 4
Recruiting
Conditions
Headache
Occipital Nerve Block
Interventions
Drug: Bupivacaine
Drug: Lidocaine
Drug: Normal saline
Drug: Dexamethasone
Procedure: Greater/lesser occipital nerve blocks
First Posted Date
2023-02-17
Last Posted Date
2024-03-21
Lead Sponsor
Mayo Clinic
Target Recruit Count
120
Registration Number
NCT05732532
Locations
🇺🇸

Mayo Clinic Minnesota, Rochester, Minnesota, United States

Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption

Not Applicable
Recruiting
Conditions
Brain Tumor
Interventions
Device: InSightec's ExAblate Neuro Model 4000 Type 2.0 (220 KHz) system
First Posted Date
2023-02-17
Last Posted Date
2024-04-11
Lead Sponsor
Mayo Clinic
Target Recruit Count
6
Registration Number
NCT05733312
Locations
🇺🇸

Mayo Clinic Minnesota, Rochester, Minnesota, United States

A Study of Remote Electrical Neuromodulation for Acute Procedural Pain

Not Applicable
Terminated
Conditions
Chronic Migraine
Interventions
Device: Nerivio ®
Device: Sham
First Posted Date
2023-02-16
Last Posted Date
2024-10-24
Lead Sponsor
Mayo Clinic
Target Recruit Count
80
Registration Number
NCT05730556
Locations
🇺🇸

Mayo Clinic in Arizona, Scottsdale, Arizona, United States

Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer

Phase 2
Recruiting
Conditions
Castration-Resistant Prostate Carcinoma
Stage IVB Prostate Cancer AJCC v8
Interventions
Procedure: Biopsy
Procedure: Biospecimen Collection
Procedure: Computed Tomography
Procedure: Echocardiography
Drug: Enzalutamide
Drug: Hyaluronidase-zzxf/Pertuzumab/Trastuzumab
Procedure: Magnetic Resonance Imaging
Other: Questionnaire Administration
First Posted Date
2023-02-16
Last Posted Date
2024-03-12
Lead Sponsor
Mayo Clinic
Target Recruit Count
25
Registration Number
NCT05730712
Locations
🇺🇸

Mayo Clinic in Florida, Jacksonville, Florida, United States

🇺🇸

Mayo Clinic in Rochester, Rochester, Minnesota, United States

🇺🇸

Mayo Clinic in Arizona, Scottsdale, Arizona, United States

Evaluating the Accuracy of Microvessel Ultrasound Imaging for Detecting Extent of Disease in Patients With Angiosarcoma of the Skin

Terminated
Conditions
Skin Angiosarcoma
Interventions
Device: Ultrasound Microvessel Imaging
First Posted Date
2023-02-15
Last Posted Date
2023-08-18
Lead Sponsor
Mayo Clinic
Target Recruit Count
1
Registration Number
NCT05729425
Locations
🇺🇸

Mayo Clinic in Rochester, Rochester, Minnesota, United States

Prospective Carotid Artery Stenosis Trial

Recruiting
Conditions
Patients With Any Degree of Carotid Artery Stenosis and Vulnerable Features in the Carotid Artery Plaque
First Posted Date
2023-02-13
Last Posted Date
2024-04-26
Lead Sponsor
Mayo Clinic
Target Recruit Count
200
Registration Number
NCT05724836
Locations
🇺🇸

Mayo Clinic Florida, Jacksonville, Florida, United States

A Study of Internet Delivered Parent Child Interaction Therapy

Not Applicable
Completed
Conditions
Disruptive Behavior
Interventions
Behavioral: Remote PCIT augmented with wearable devices
First Posted Date
2023-02-13
Last Posted Date
2024-04-01
Lead Sponsor
Mayo Clinic
Target Recruit Count
5
Registration Number
NCT05725525
Locations
🇺🇸

Mayo Clinic Minnesota, Rochester, Minnesota, United States

Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation

Phase 1
Not yet recruiting
Conditions
Malignant Central Nervous System Neoplasm
Interventions
Drug: Anhydrous Enol-oxaloacetate
Other: Best Practice
Procedure: Biospecimen Collection
Procedure: Magnetic Resonance Spectroscopic Imaging
Other: Questionnaire Administration
First Posted Date
2023-02-09
Last Posted Date
2024-08-26
Lead Sponsor
Mayo Clinic
Target Recruit Count
24
Registration Number
NCT05720624
Locations
🇺🇸

Mayo Clinic in Rochester, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath